EchoGo Amyloidosis vs Eko Low Ejection Fraction Tool (ELEFT)
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 70/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
Tool A, EchoGo Amyloidosis, is specialized for the early detection of cardiac amyloidosis by analyzing echocardiogram video clips within cardiology workflows. Tool B, Eko Low Ejection Fraction Tool, focuses on identifying low ejection fraction, an indicator of heart failure, through AI analysis of ECG and heart sound recordings from digital stethoscopes during routine physical exams. While both are FDA-cleared AI tools for cardiac screening, their distinct input modalities and specific target conditions make them complementary for different stages or types of cardiac assessment rather than direct competitors.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
EchoGo Amyloidosis is designed to aid in the early detection of cardiac amyloidosis (CA) by analyzing echocardiogram video clips. The Eko Low Ejection Fraction Tool (ELEFT) aids clinicians in the early detection of low ejection fraction, which is a key indicator of heart failure.
EchoGo Amyloidosis analyzes echocardiogram video clips. The Eko Low Ejection Fraction Tool integrates with Eko digital stethoscopes to analyze ECG and heart sound recordings.
EchoGo Amyloidosis offers seamless integration with existing clinical workflows and IT infrastructure, including PACS, DICOM, and HL7. The Eko Low Ejection Fraction Tool integrates with FDA-cleared Eko digital stethoscopes and is part of the SENSORAu2122 Cardiac Early Detection Platform.
EchoGo Amyloidosis provides a diagnostic output of 'suggestive' or 'not suggestive' of cardiac amyloidosis with high diagnostic accuracy (85% sensitivity, 93% specificity). The Eko Low Ejection Fraction Tool aids in the early identification of heart failure risk by detecting low ejection fraction and provides results in approximately 15 seconds.
More Comparisons
Backers
Who funded each tool's parent company.